Mraz Amerine & Associates Inc. increased its position in Brookfield Co. (NYSE:BN - Free Report) by 2.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,527 shares of the company's stock after acquiring an additional 5,447 shares during the period. Brookfield makes up about 2.0% of Mraz Amerine & Associates Inc.'s portfolio, making the stock its 11th biggest holding. Mraz Amerine & Associates Inc.'s holdings in Brookfield were worth $11,118,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in BN. Pittenger & Anderson Inc. increased its stake in shares of Brookfield by 14.9% in the fourth quarter. Pittenger & Anderson Inc. now owns 1,563 shares of the company's stock worth $90,000 after acquiring an additional 203 shares during the period. Pinnacle Bancorp Inc. lifted its holdings in shares of Brookfield by 29.5% in the 4th quarter. Pinnacle Bancorp Inc. now owns 969 shares of the company's stock valued at $56,000 after buying an additional 221 shares during the period. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Brookfield by 10.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 2,579 shares of the company's stock valued at $148,000 after buying an additional 245 shares during the period. Joel Isaacson & Co. LLC boosted its stake in shares of Brookfield by 5.3% in the fourth quarter. Joel Isaacson & Co. LLC now owns 5,625 shares of the company's stock worth $323,000 after buying an additional 283 shares during the last quarter. Finally, First Trust Direct Indexing L.P. grew its holdings in Brookfield by 2.9% during the third quarter. First Trust Direct Indexing L.P. now owns 10,374 shares of the company's stock worth $551,000 after acquiring an additional 292 shares during the period. Institutional investors and hedge funds own 61.60% of the company's stock.
Brookfield Price Performance
BN stock traded down $1.35 during trading on Friday, hitting $58.68. The stock had a trading volume of 3,478,451 shares, compared to its average volume of 2,257,443. The company's 50-day moving average price is $58.54 and its two-hundred day moving average price is $55.00. Brookfield Co. has a twelve month low of $38.18 and a twelve month high of $62.78. The stock has a market capitalization of $96.59 billion, a P/E ratio of 195.60 and a beta of 1.57. The company has a debt-to-equity ratio of 1.40, a current ratio of 1.21 and a quick ratio of 1.09.
Brookfield (NYSE:BN - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.88 by $0.13. Brookfield had a return on equity of 3.93% and a net margin of 0.75%. As a group, research analysts predict that Brookfield Co. will post 3.85 EPS for the current fiscal year.
Brookfield Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date is Friday, March 14th. Brookfield's payout ratio is 106.67%.
Analysts Set New Price Targets
BN has been the topic of several recent research reports. Morgan Stanley initiated coverage on Brookfield in a research report on Thursday, January 23rd. They issued an "overweight" rating and a $80.00 price objective on the stock. BMO Capital Markets reissued an "outperform" rating and set a $62.00 price target (up from $50.00) on shares of Brookfield in a report on Friday, November 15th. Scotiabank lifted their price objective on shares of Brookfield from $69.00 to $71.00 and gave the company a "sector outperform" rating in a report on Monday, February 3rd. CIBC increased their target price on shares of Brookfield from $68.00 to $70.00 and gave the stock an "outperformer" rating in a research note on Thursday, January 23rd. Finally, TD Securities lifted their price target on Brookfield from $74.00 to $75.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, Brookfield has an average rating of "Moderate Buy" and a consensus target price of $64.00.
View Our Latest Stock Report on Brookfield
Brookfield Profile
(
Free Report)
Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. It manages a range of public and private investment products and services for institutional and retail clients.
Featured Stories

Before you consider Brookfield, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brookfield wasn't on the list.
While Brookfield currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.